| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate |
2008-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59cc43f3fb6e206c259679eb8025d89f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eae0531be8ba547b64a59e8a32cbcda4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64c9900e1000fbb7b796a6b81bd3ac00 |
| publicationDate |
2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011150917-A1 |
| titleOfInvention |
Small Cationic Antimicrobial Peptides |
| abstract |
Cationic bacteriocin and lantibiotic peptides are provided and their immunomodulatory activities are described. Methods are provided for selectively enhancing innate immunity. Other methods are provided for selectively suppressing a proinflammatory response. Other methods are provided for identifying a compound or compounds which modulate an innate immune response. Pharmaceutical compositions comprising the cationic bacteriocin and lantibiotic peptides or polynucleotides are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014142028-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013119821-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015368316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113521007-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9326523-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112004548-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023075675-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015038339-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021202816-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019162301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4056195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018195467-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105802982-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207374-B2 |
| priorityDate |
2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |